FDA warns Allergan on Aczone promotion
By admin at 31 August, 2009, 3:00 pm
Washington ?An advertisement for Aczone (Allergan), a gel used to treat mild-to-moderate acne, “grossly overstates” the drug?s effectiveness, the Food and Drug Administration (FDA) stated in a letter released Aug. 21
View original post here:
FDA warns Allergan on Aczone promotion
Related posts:
- FDA: Allergan Aczone ads were misleading The U.S. Food and Drug Administration on Friday released a...
- FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin ROCKVILLE, Md., Feb. ...
- Dapsone (aczone) 5% gel for the treatment of acne. Authors: Coutinho B PMID: 20148498 [PubMed - in process] (Source:...
- Classification of benzoyl peroxide as safe and effective and revision of labeling to drug facts format; topical acne drug products for… Authors: We, the Food and Drug Administration (FDA), are issuing...
- Acne drug may be a defense against HIV BALTIMORE, March 24 (UPI) -- U.S. researchers said an antibiotic...
Categories :
Acne News

No comments yet.